Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fragmin in pediatric venous thromboembolism
NCT00952380Phase 2Completed
- Sponsor
- Pfizer
- Start
- Aug 2009
- Primary completion
- Mar 2018
- Countries
- 5
01
Overview
A Phase 2 trial of dalteparin in venous thromboembolism (VTE), sponsored by Pfizer. Started Aug 2009; status: completed.
02
Drugs
dalteparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00952380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00952380.